Analytical Data
-
基因名
C22orf25
- Application
-
别名
TANGO2; C22orf25; Transport and Golgi organization Protein 2 homolog
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q6ICL3
-
表达区间
1-276aa
-
氨基酸序列
MCIIFFKFDPRPVSKNAYRLILAANRDEFYSRPSKLADFWGNNNEILSGLDMEEGKEGGTWLGISTRGKLAALTNYLQPQLDWQARGRGELVTHFLTTDVDSLSYLKKVSMEGHLYNGFNLIAANLSTAKGDVICYYGNRGEPDPIVLTPGTYGLSNALLETPWRKLCFGKQLFLEAVERSQALPKDVLIASLLDVLNNKEAQLPDPAIEDQGGEYVQPMLSKYAAVCVRCPGYGTRTNTIILVDADGHVTFTERSMMDKDLSHWETRTYEFTLQS
-
分子量
57.3 KDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C22orf25, also known as KIAA1462, is a human gene that has garnered attention due to its potential role in various biological processes and its implications in certain diseases. The protein encoded by C22orf25 is thought to be involved in cellular functions such as cell proliferation, differentiation, and apoptosis. Recent studies have indicated that this protein may play a significant role in cancer progression, although the exact mechanisms remain to be fully elucidated. The interest in C22orf25 is heightened by its association with metabolic pathways and immune responses, suggesting that it could serve as a biomarker for disease diagnosis or progression. Additionally, research into the recombinant production of C22orf25 is essential for understanding its structure-function relationship, which could provide insights into its biological activity and interaction with other cellular components. The development of recombinant C22orf25 protein allows for the exploration of its properties in vitro, paving the way for potential therapeutic applications. By integrating biochemical, molecular biology, and genetic approaches, studies focusing on C22orf25 aim to uncover its precise roles in health and disease, making it a promising target for future research in fields such as oncology and metabolic disorders.
